Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of ropivacaine and hydrocodone for nail-procedure associated pain management. The investigators hypothesize that ropivacaine with hydrocodone will be superior to ropivacaine with acetaminophen and ibuprofen for managing pain.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05544734
Study type Interventional
Source Weill Medical College of Cornell University
Contact
Status Completed
Phase Phase 4
Start date November 10, 2022
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT00925418 - Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer Phase 3
Not yet recruiting NCT04092413 - Subclinical Nail Involvement in Relevant Skin Diseases
Completed NCT04941807 - Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome Phase 4
Completed NCT03991936 - Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis Phase 4
Withdrawn NCT04384679 - Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery Phase 4
Active, not recruiting NCT05482763 - Mycosis Culture Collection From Dermatological Isolated
Withdrawn NCT04422795 - The Evaluation of External Thermomechanical Stimulation for Pain Reduction in Patients Undergoing Nail Injection Phase 4
Completed NCT01330706 - Efficacy of Intraoperative Surgical Scrubbing in Reducing Bacterial Load After Nail Removal Surgery Phase 4